Iguratimod prevents renal fibrosis in unilateral ureteral obstruction model mice by suppressing M2 macrophage infiltration and macrophage–myofibroblast transition
Iguratimod is a novel synthetic, small-molecule immunosuppressive agent used to treat rheumatoid arthritis. Through ongoing exploration of its role and mechanisms of action, iguratimod has been observed to have antifibrotic effects in the lung and skin; however, its effect on renal fibrosis remains...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2024-12-01
|
| Col·lecció: | Renal Failure |
| Matèries: | |
| Accés en línia: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2327498 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|